Xact Kapitalforvaltning’s Bio-Rad Laboratories Class A BIO Stock Holding History

Xact Kapitalforvaltning’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.18M	Hold	3,372	–	–	0.03%	462
2019 Q4	$1.25M	Hold	3,372	–	–	0.02%	539
2019 Q3	$1.12M	Hold	3,372	–	–	0.02%	536
2019 Q2	$1.05M	Hold	3,372	–	–	0.02%	562
2019 Q1	$1.03M	Hold	3,372	–	–	0.02%	572
2018 Q4	$783K	Buy	3,372 +600	+22%	+$161K	0.02%	643
2018 Q3	$868K	Hold	2,772	–	–	0.02%	647
2018 Q2	$800K	Buy	2,772 +200	+8%	+$55.2K	0.02%	671
2018 Q1	$643K	Buy	2,572 +800	+45%	+$204K	0.01%	703
2017 Q4	$423K	Buy	+1,772	New	+$429K	0.01%	737

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Xact Kapitalforvaltning's BIO Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Bio-Rad Laboratories Class A (BIO) position steady in Q1 2020 at 3,372 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #462.

Xact Kapitalforvaltning first reported a position in BIO in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.25M in Q4 2019. 407 funds tracked by Wall St. Rank hold BIO as of Q1 2020.

Xact Kapitalforvaltning held 3,372 shares of Bio-Rad Laboratories Class A worth $1.18M as of Q1 2020.
Xact Kapitalforvaltning left its Bio-Rad Laboratories Class A share count unchanged in Q1 2020.
Bio-Rad Laboratories Class A made up 0.03% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #462 holding.
Xact Kapitalforvaltning first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Bio-Rad Laboratories Class A position peaked at $1.25M in Q4 2019.
407 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.